Pharmaron Beijing Co (HKSE:03759) Other Operating Expense : HK$1,212 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Other Operating Expense?

Pharmaron Beijing Co's Other Operating Expense for the three months ended in Mar. 2025 was HK$10 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was HK$1,212 Mil.

Pharmaron Beijing Co's quarterly Other Operating Expense increased from Sep. 2024 (HK$-582 Mil) to Dec. 2024 (HK$1,182 Mil) but then declined from Dec. 2024 (HK$1,182 Mil) to Mar. 2025 (HK$10 Mil).

Pharmaron Beijing Co's annual Other Operating Expense increased from Dec. 2022 (HK$1,068 Mil) to Dec. 2023 (HK$1,138 Mil) and increased from Dec. 2023 (HK$1,138 Mil) to Dec. 2024 (HK$1,227 Mil).

Pharmaron Beijing Co Other Operating Expense Historical Data

The historical data trend for Pharmaron Beijing Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Other Operating Expense Chart

Pharmaron Beijing Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

498.55

876.70

1,068.40

1,138.47

1,226.75

Pharmaron Beijing Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															12.59	601.74	-582.12	1,182.07	10.07

Pharmaron Beijing Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$1,212 Mil.

Pharmaron Beijing Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaron Beijing Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (HKSE:03759) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

300759:China

Address

No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, HKG

Website

https://www.pharmaron.com

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.

Executives

Hsbc Holdings Plc	2106 Person having a security interest in shares
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Gic Private Limited	2102 Investment manager
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Matthews International Capital Management, Llc	2102 Investment manager
First H Share Award And Scheme Of Pharmaron Beijing Co., Ltd.	2301 Trustee
Kastle Limited	2301 Trustee
Jian Xin Bei Jing Tou Zi Ji Jin Guan Li You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Jian Xin Xin Tuo You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you

Pharmaron Beijing Co Headlines

No Headlines